Enjoy complimentary customisation on priority with our Enterprise License!
The assisted reproductive technology market size is forecast to increase by USD 8.23 billion between 2022 and 2027, accelerating at a CAGR of 5.79%. In 2017, the US held the largest market share, projecting an annual revenue of USD 4.95 billion. The research report of the Assisted Reproductive Technology Market offers industry forecasts and segmentation based on Application including fertility clinics, hospitals, and others. It also segments the market by Type, which comprises IVF and Artificial Insemination. Geographically, the report covers Europe, North America, Asia, and Rest of World (RoW). The market size, historical data (2017-2021), and future forecasts are presented in terms of value (in USD billion) for all these mentioned segments.
To learn more about this report, Download Report Sample
The increase in rate of infertility and obesity-related cases is a key factor driving the market growth. The global assisted reproductive technology (ART) market is propelled by two key factors: the increasing prevalence of infertility and obesity-related issues. Infertility is a widespread concern, impacting many couples due to factors like advanced maternal age, hormonal disorders, genetics, lifestyle choices, and infections. As infertility rates rise, there's a growing demand for ART procedures like in vitro fertilization (IVF) and intrauterine insemination (IUI). This surge in demand fuels the ART market as more individuals and couples turn to these techniques to overcome infertility and achieve successful pregnancies.
Obesity has also become a global epidemic, adversely affecting fertility for both men and women. Conditions like polycystic ovary syndrome (PCOS) and insulin resistance, linked to obesity, disrupt normal reproductive function and increase infertility risk. Moreover, obesity can affect the success rates of ART procedures. The mounting cases of obesity-related infertility drive the demand for ART treatments to aid those facing fertility challenges, contributing to the growth of the ART market. These combined factors are expected to influence the ART market positively during the forecast period.
Fertility Clinics Segment is the Leading Segment to Dominate the Market
The fertility clinics segment shows a gradual increase in the market share of USD 13.41 billion in 2017 and continue to grow by 2021. Fertility clinics dominated the global ART market owing to a worldwide increase in the number of fertility centers to meet the unmet and increasing number of fertility patients that have subsequently increased consumption of ART solutions. A key factor the increase would influence the inflow of infertility patients is the high increase in the success rate of infertility clinics globally. Moreover, an increase in infertility patients will drive the infertility treatment market during the forecast period.
Assisted Reproductive Technology Market - Revenue Share by Application Segment, 2017-2027
For more details on other segments, Download Sample Report
Europe Holds a Prominent Position in the Assisted Reproductive Technology Market
Europe is estimated to contribute 32% to the growth of the global market during the forecast period. The growth of the European market is driven by the increasing elderly population facing infertility issues due to declining egg quality, impacting couples' ability to conceive. In 2022, major contributions to the European market came from Italy, the UK, Germany, France, and Spain. With fertility rates averaging around 1.5 children per woman in most European countries, there's a growing trend of women seeking advanced infertility treatments, creating opportunities for hospitals and fertility clinics in the forecast period.
Government and non-government organizations have ramped up awareness campaigns to educate the public about fertility complications and treatment options. End-users in the region encounter challenges such as high treatment costs and stringent regulations governing fertility services at hospitals and clinics. Belgium, Israel, and the Czech Republic have become fertility tourism hubs, offering favorable reimbursement policies and advanced ART techniques. Additionally, countries like Israel, Belgium, France, Slovenia, and the Netherlands provide full insurance coverage for ART, with varying coverage for treatment cycles. Israel's government has also subsidized ART costs.
Assisted Reproductive Technology Market Size, By Region, Global 2017-2027
To understand geographic trends Download Report Sample
The Assisted Reproductive Technology Market is fragmented in nature. Some significant players include Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd.
The assisted reproductive technology market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027
Assisted Reproductive Technology Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.79% |
Market growth 2023-2027 |
USD 8.23 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.37 |
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 32% |
Key countries |
US, UK, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp., Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.